Grant Life Sciences (“Grant”)
Receives a Waiver from N.I.R. Group That Allows Grant to Pursue
Alternate Financing
LOS ANGELES (Business Wire EON/PRWEB ) March 31, 2008 --
Grant
Life Sciences (OTC Bulletin Board: GLIF) announced today it has
received a waiver from The N.I.R. Group, LLC (“N.I.R.
Group”), a Roslyn, N.Y.-based hedge fund that
allows Grant to pursue alternate financing to pay down, in whole or in
part, an existing financing debt to N.I.R.
“The Company has greatly appreciated NIR’s
support over the last two years and these important developments related
to N.I.R. Group will allow Grant to further advance its serum-based
test for cervical cancer in the largest market in the world, China,”
said Hun-Chi Lin, Ph.D., Grant’s President and
Chief Scientist.
About Grant Life Sciences Inc.
Grant Life Sciences Inc., a development stage company, engages in the
research, development, marketing, and sale of diagnostic kits for the
screening, monitoring, and diagnosis of diseases with emphasis on women’s
health, infectious diseases, and cancers.
Forward-Looking Safe Harbor Statement
With the exception of historical information, the matters discussed in
this press release are "forward-looking statements" that involve a
number of risks and uncertainties. The actual future results of Grant
Life Sciences could differ significantly from those statements. Factors
that could cause actual results to differ materially include risks and
uncertainties such as the inability to finance the company's operations
or expansion, inability to hire and retain qualified personnel, changes
in the general economic climate, including rising interest rates and
unanticipated events such as terrorist activities, results of clinical
trials, and market acceptance of the Company's products. In some cases,
"forward-looking statements" can be identified by terminology such as
"may," "will," "should," "expect," "plan," "anticipate," "believe,"
"estimate," "predict," "potential" or "continue," or other comparable
terminology. Although Grant Life Sciences believes that the expectations
reflected in the "forward-looking" statements are reasonable, such
statements should not be regarded as a representation by the Company, or
any other person, that such "forward-looking statements" will be
achieved. Grant Life Sciences undertakes no duty to update any of the
"forward-looking statements," whether as a result of new information,
future events or otherwise. In light of the foregoing, readers are
cautioned not to place undue reliance on such "forward-looking
statements." For further risk factors associated with our Company,
review our SEC filings.
See the original story at: http://eon.businesswire.com/releases/grant/life_sciences/prweb818254.htm
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1TcXVhLVN1bW0tTWFnbi1TdW1tLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
